Pro-medics.com, the online pharmaceutical company, announced their sales addition of the new herpes medication, Generic Valtrex. This innovative drug treatment has just recently become FDA approved for the prevention and treatment of Genital Herpes.

Valtrex is an anti-viral medication that has been medically proven to treat both cold sores and shingles, as well as shorten the length of Herpes treatment time.

Ralphe Rowe, Company Product manager explained, “Unfortunately, Genital Herpes has been currently increasing in appearance amongst the American public, involving a series of embarrassing and uncomfortable symptoms.” “Pro-medics online is proud to offer its customers a discreet and medically effective solution to treating the virus.”

Pro-medics online, offers its clientele free anonymous phone consultations, providing customers with live medical advice and support. This unique form of customer service alleviates the requirement of a prior prescription or potentially embarrassing visit to the doctor.

Pro-medics pharmaceuticals is known for offering its customers first rate service and quality medications at highly discounted prices. The company therefore stocks the preferred generic version of Valacyclovir, otherwise referred to as Generic Valtrex. Generic Valtrex is just as effective as its name brand counterpart, only it’s available at less than half the original drug’s price.

Regarding this decision, Pro-medics President of Sales, Sarah Tenne, explained “Our Company places an emphasis on bringing its customers quality drugs at discount prices. We see no reason for product quality to come at the expense of customer affordability”.

About Pro-Medics
Pro-Medics.com is an online pharmacy website, offering customers popularly prescribed prescription drugs. Pro-Medics also specializes in erectile dysfunction and diet pills, offering a full line of both popular brand name medications as well as their discounted generic counterparts.

For the complete article, please refer to http://www.prweb.com/releases/2009/07/prweb2610284.htm.